The FDA Modernization Act opens the door for more innovative alternatives to animal testing for drug discovery and development

The challenges of complex disorders require collaboration, embracing technological developments, and acknowledging the gaps in access to medicine

Three companies – Cardinal Health, REGENXBIO, and Beacon Therapeutics – help us explore gene therapy development in the ophthalmic space

Nick Armstrong, Senior Director of Digital Enablement at CAI, discusses the realities of digital enablement, artificial intelligence, and more.

Clinical trials are ripe for improvement; here’s how centralized study information can help

The story of how Caribou Biosciences developed a hybrid RNA-DNA guide to increase Cas9 specificity.

How to find the right balance in cell therapy manufacturing.

Machine learning has significant promise, but we should never overlook the importance of the human factor.

Get your pharma heroes nominated by January 12!

Can genetically engineering yeast be used to produce safe and scalable schizophrenia plant-inspired drugs?